Navigating the Risks of Angiomas and Aneurysms in the Brain

The brain depends entirely on a finely tuned network of blood vessels to function. When those vessels develop structural abnormalities – whether in the form of tangled clusters or dangerous bulges – the neurological consequences can range from subtle symptoms to life-threatening emergencies. Two of the most clinically significant vascular anomalies in neuropsychology are angiomas and aneurysms. Understanding how they form, what they do to the brain, and how they are managed is essential for anyone seeking to understand the intersection of brain structure and neurological function.

What are cerebral angiomas? 🔗

The term angioma broadly refers to a cluster of abnormal blood vessels in the brain. These are not tumors in the conventional sense – they do not involve uncontrolled cell growth – but they are malformed vascular structures that disrupt normal blood flow and can bleed into surrounding brain tissue.

Vascular malformations of the brain are generally classified based on which segment of the vasculature is abnormal and whether arteriovenous shunting of blood is present. The major types of angiomas include:

Cavernous angiomas (cavernomas) 🔗

Cerebral cavernous malformations (CCMs), also called cavernous angiomas or cavernomas, are groups of capillaries that form irregular, raspberry-shaped lesions in the brain. The walls of these capillaries are unusually thin and weak, missing key structural components like elastic fibers and smooth muscle. This makes them prone to leaking blood into surrounding tissue. Cleveland Clinic notes that the lesions can range from a fraction of an inch to dime-sized or larger, and their structural fragility means they are more likely to bleed than normal vessels.

CCMs can occur sporadically or run in families. Research published in PMC identifies three associated genes – CCM1, CCM2, and CCM3 – all inherited in an autosomal dominant pattern, with a higher prevalence among Hispanic populations. Up to 20% of cases are familial, and these are more likely to involve multiple lesions.

Venous angiomas (developmental venous anomalies) 🔗

Venous angiomas, more formally known as developmental venous anomalies (DVAs), are enlarged veins that drain a normal segment of brain. Unlike cavernomas, they are considered a residual variant of normal embryological venous drainage. According to neurological research, DVAs are asymptomatic in the vast majority of cases and are usually discovered incidentally on brain scans ordered for unrelated reasons. Headaches, seizures, or neurological deficits occur only very rarely.

Arteriovenous malformations (AVMs) 🔗

Arteriovenous malformations (AVMs) are complex tangles of arteries and veins connected by abnormal channels, with no intervening capillary bed. According to Medscape, AVMs produce neurological dysfunction primarily through rupture and intracerebral hemorrhage, accounting for 41-79% of symptomatic presentations. AVMs can also cause seizures in approximately 15-40% of patients, and in rarer cases, a progressive neurological deficit through a “steal phenomenon” – where abnormal vessels divert blood flow away from adjacent healthy brain tissue.

Symptoms of cerebral angiomas 🔗

Many people with cerebral angiomas never know they have them. Pacific Neuroscience Institute explains that when symptoms do appear in unruptured malformations, they stem from the lesion pressing on brain tissue, triggering inflammation, leaking abnormal substances, or altering blood flow. These symptoms may include chronic headaches, seizures, or stroke-like effects such as changes in speech, vision, motor function, or sensation.

When a vascular malformation ruptures, the clinical picture changes sharply. A sudden, severe headache – often described as the worst of one’s life – along with nausea, vomiting, sensitivity to light, confusion, weakness, or loss of consciousness signals a hemorrhagic event. This constitutes a neurological emergency.

What is a cerebral aneurysm? 🔗

While angiomas involve clusters of malformed vessels, an aneurysm is a different type of vascular anomaly: a localized bulge or ballooning in the wall of a single artery, caused by a weakness in that wall. Barrow Neurological Institute describes them as balloon-like weak spots along a blood vessel that may burst and bleed into the brain, potentially causing life-threatening complications even without rupture, by pressing on nearby nerves or tissue.

Johns Hopkins Medicine notes that most cerebral aneurysms are small – under 10 millimeters in diameter – and cause no symptoms. They most commonly develop at arterial branch points, especially along the circle of Willis, the ring of arteries at the base of the brain.

Types of cerebral aneurysms 🔗

The most common type is the saccular (berry) aneurysm, a rounded, blood-filled sac that bulges from one side of an artery, typically at a branch point. Fusiform aneurysms involve ballooning of the entire circumference of a vessel rather than one side. Mycotic aneurysms arise from bacterial, fungal, or viral infections that weaken arterial walls. Each type carries different risks and management considerations.

What causes cerebral aneurysms? 🔗

Aneurysms form when artery walls become thin or structurally compromised. Brigham and Women’s Hospital identifies several contributing factors, including smoking, family history, and demographic variables – women between the ages of 30 and 60 are more susceptible, and Black and Latino individuals face roughly twice the risk compared to white individuals. Genetic conditions such as alpha-1-antitrypsin deficiency and connective tissue disorders also elevate risk.

Once an aneurysm exists, certain triggers can push it toward rupture. WebMD reports that high blood pressure is the most common precipitating factor, followed by physical strain, intense emotional stress, and the use of stimulant drugs like cocaine or amphetamines. Blood thinners can also increase the risk of bleeding.

Neurological impact of a ruptured aneurysm 🔗

When an aneurysm ruptures, blood spills into the subarachnoid space – the area between the brain and the protective tissue layers surrounding it – causing a subarachnoid hemorrhage (SAH). Cleveland Clinic reports that roughly 90% of all SAHs result from ruptured brain aneurysms. The released blood raises intracranial pressure, causes the brain to swell, and can trigger a cascade of secondary complications.

One of the most dangerous secondary complications is vasospasm, which Mayfield Brain & Spine explains typically occurs 5 to 10 days after rupture. Toxic byproducts of broken-down red blood cells cause nearby arteries to narrow and spasm, reducing blood flow and potentially causing a secondary stroke. The National Institute of Neurological Disorders and Stroke (NINDS) further identifies delayed cerebral ischemia (DCI) as one of the leading causes of post-rupture death and disability, occurring between 3 and 14 days after bleeding and proving difficult to treat.

The survival statistics are sobering. Cleveland Clinic data indicates that around 25% of people who experience a brain aneurysm rupture die within 24 hours, and approximately 50% within three months due to complications. Of those who survive, about 66% experience permanent brain damage.

Diagnosis: how are these conditions detected? 🔗

Both angiomas and aneurysms are frequently discovered incidentally during brain imaging ordered for unrelated complaints. When symptoms do arise, clinicians rely on several imaging modalities to identify and characterize these conditions.

MRI (Magnetic Resonance Imaging) is considered essential for detecting cavernomas and AVMs, as these lesions often do not show up clearly on CT scans. CT angiography (CTA) and MR angiography (MRA) are particularly useful for visualizing the shape and blood supply of aneurysms and AVMs. NINDS describes cerebral angiography as the gold standard for locating small aneurysms and clearly mapping the morphology of AVMs to guide treatment. A lumbar puncture (spinal tap) may be performed if a ruptured aneurysm is suspected but not clearly visible on imaging – the presence of blood in the cerebrospinal fluid confirms hemorrhage.

Treatment approaches 🔗

Treatment decisions depend on the type, size, location, and symptom profile of the malformation, as well as the patient’s overall health. Not all conditions require immediate intervention.

Managing angiomas 🔗

For cavernomas that are not bleeding, the primary approach is watchful waiting with periodic imaging to monitor any changes. If the malformation bleeds, causes seizures, or produces worsening neurological symptoms, surgery to remove the lesion becomes an option. NINDS notes that medications can help manage symptoms like seizures and headaches, and that people with this condition typically require lifelong monitoring because CCMs can change in size and number over time.

Treating aneurysms 🔗

For small, unruptured aneurysms without significant risk factors, regular imaging surveillance may be all that is recommended. When intervention is needed, two primary approaches exist. Surgical clipping is an open-brain procedure in which a neurosurgeon places a small metal clip at the base of the aneurysm to cut off its blood supply – generally producing a durable, long-term result. Endovascular coiling is a less invasive technique in which a catheter, inserted through the wrist or groin, threads platinum coils into the aneurysm, prompting clot formation that seals it off from circulation. A newer variation involves placing a flow-diverting stent across the base of the aneurysm to redirect blood flow and encourage the aneurysm to shrink over time.

Following a rupture, additional treatments address complications: antiseizure medications, calcium channel blockers (such as nimodipine) to reduce vasospasm, and drainage shunts to manage excess cerebrospinal fluid. Rehabilitation – including physical, occupational, and speech therapy – is often necessary for those who survive with neurological deficits.

The role of early detection and risk reduction 🔗

Because both angiomas and aneurysms can exist silently for years, early detection through screening is particularly important for high-risk individuals. Brigham and Women’s Hospital recommends that people with two or more close relatives diagnosed with brain aneurysms consider screening with MRA, as family history is a meaningful risk factor. Genetic counseling is similarly valuable for individuals with known familial cavernous malformation genes.

Modifiable risk factors for aneurysm formation and rupture – including high blood pressure, smoking, alcohol excess, and stimulant drug use – provide concrete targets for prevention. Controlling blood pressure remains the single most impactful lifestyle measure. For AVMs and cavernomas with a genetic basis, ongoing research into the molecular mechanisms of abnormal angiogenesis may eventually yield targeted therapies. Research published in Stroke (American Heart Association) highlights that all genes associated with vascular malformations of the brain identified so far have known roles in angiogenesis and vascular stabilization – pointing toward future therapeutic targets.

What do you think? Given that both angiomas and aneurysms can remain completely silent for years, how should neuropsychology and public health intersect to improve early identification – especially in people with a family history? And when we consider the emotional weight of living with an unruptured but diagnosed brain anomaly, what psychological support structures do you think should be integral to patient care?

References

1. https://pmc.ncbi.nlm.nih.gov/articles/PMC10370599/
2. https://www.ninds.nih.gov/health-information/disorders/cerebral-cavernous-malformations
3. https://my.clevelandclinic.org/health/diseases/21594-cavernous-hemangioma
4. https://pmc.ncbi.nlm.nih.gov/articles/PMC7886037/
5. https://emedicine.medscape.com/article/1160167-overview
6. https://www.pacificneuroscienceinstitute.org/stroke-neurovascular/conditions-and-treatments/brain-vascular-malformation/
7. https://www.barrowneuro.org/condition/brain-aneurysm/
8. https://www.hopkinsmedicine.org/health/conditions-and-diseases/cerebral-aneurysm
9. https://www.brighamandwomens.org/neurosurgery/brain-aneurysm
10. https://www.webmd.com/brain/brain-aneurysm
11. https://my.clevelandclinic.org/health/diseases/16800-brain-aneurysm
12. https://mayfieldclinic.com/pe-aneurrupt.htm
13. https://www.ninds.nih.gov/health-information/disorders/cerebral-aneurysms
14. https://www.ahajournals.org/doi/10.1161/strokeaha.109.563692